Nutropin AQ Related Published Studies
Well-designed clinical trials related to Nutropin AQ (Human Growth Hormone)
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children. [2004.07]
Well-designed clinical trials possibly related to Nutropin AQ (Human Growth Hormone)
Growth hormone treatment for growth failure in pediatric patients with Crohn's disease. [2008.11]
A randomized controlled crossover trial of the effect of ginseng consumption on the immune response to moderate exercise in healthy sedentary men. [2008.10]
Efficacy and safety of individualized growth hormone treatment in adult Japanese patients with growth hormone deficiency. [2008.10]
Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. [2008.09]
Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial. [2008.08.06]
The Effects of Growth Hormone and/or Testosterone on Whole Body Protein Kinetics and Skeletal Muscle Gene Expression in Healthy Elderly Men: A Randomized Controlled Trial. [2008.08]
Induction of tolerance of dopaminergic responses in man. [2008.08]
Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). [2008.08]
Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. [2008.08]
Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial. [2008.07]
Somatotropic responses to soy protein alone and as part of a meal. [2008.07]
Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone. [2008.07]
Early-phase neuroendocrine responses and strength adaptations following eccentric-enhanced resistance training. [2008.07]
The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study. [2008.07]
Growth Hormone Treatment for Growth Failure in Pediatric Patients with Crohn's Disease. [2008.06.25]
A Randomised Study of Two Doses of Biosynthetic Human Growth Hormone on Final Height of Pubertal Children with Growth Hormone Deficiency. [2008.06.12]
Frequent intravenous pulses of growth hormone together with glutamine supplementation in prolonged critical illness after multiple trauma: effects on nitrogen balance, insulin resistance, and substrate oxidation. [2008.06]
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. [2008.06]
Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin. [2008.05.15]
Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial. [2008.05.10]
24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment. [2008.05]
Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons. [2008.05]
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information. [2008.05]
Weekly paclitaxel in the adjuvant treatment of breast cancer. [2008.04.17]
Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. [2008.04]
Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients. [2008.04]
Changes in insulin sensitivity and glucose metabolism during therapy with recombinant human growth hormone in short children born small for gestational age show a negative correlation with baseline measurements. [2008.04]
Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. [2008.04]
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial. [2008.03.01]
Growth hormone treatment and fat redistribution in children born small for gestational age. [2008.03]
The growth hormone response to repeated bouts of sprint exercise with and without suppression of lipolysis in men. [2008.03]
Pituitary and/or Peripheral Estrogen-Receptor {alpha} Regulates Follicle-Stimulating Hormone Secretion, Whereas Central Estrogenic Pathways Direct Growth Hormone and Prolactin Secretion in Postmenopausal Women. [2008.03]
Gonadal Status and Body Mass Index Jointly Determine Growth Hormone (GH)-Releasing Hormone/GH-Releasing Peptide Synergy in Healthy Men. [2008.03]
A single circuit-resistance exercise has no effect on plasma obestatin levels in female college students. [2008.03]
Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study. [2008.02]
Effects of oral ingestion of amino acids and proteins on the somatotropic axis. [2008.02]
Enhancement of muscle mitochondrial function by growth hormone. [2008.02]
Relationship between GH-induced metabolic changes and changes in body composition: a dose and time course study in GH-deficient adults. [2008.02]
Growth hormone replacement therapy in adults with growth hormone deficiency improves maximal oxygen consumption independently of dosing regimen or physical activity. [2008.01]
Human blood neutrophil responses to prolonged exercise with and without a thermal clamp. [2008.01]
Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome. [2008.01]
Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age. [2008]
A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature. [2008]
A randomised study of two doses of biosynthetic human growth hormone on final height of pubertal children with growth hormone deficiency. [2008]
Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: A pilot open, randomized, and controlled clinical trial. [2007.12.27]
Metabolic effects of a growth hormone-releasing factor in patients with HIV. [2007.12.06]
Overture for growth hormone: requiem for interleukin-6? [2007.12]
Effects of an amino acid/creatine energy supplement on the acute hormonal response to resistance exercise. [2007.12]
Effect of protein-rich feeding on recovery after intense exercise. [2007.12]
Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study. [2007.11.30]
Effects of a multi-nutrient supplement on exercise performance and hormonal responses to resistance exercise. [2007.11]
Cardiovascular effects of intravenous ghrelin infusion in healthy young men. [2007.11]
Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. [2007.11]
Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. [2007.11]
Reduction in proliferation with six months of letrozole in women on hormone replacement therapy. [2007.11]
Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle. [2007.10.08]
Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets. [2007.10]
Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. [2007.10]
Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial. [2007.10]
Milk consumption and the prepubertal somatotropic axis. [2007.09.27]
A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancer. [2007.09.01]
Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects. [2007.09]
Estimation of the size and shape of GH secretory bursts in healthy women using a physiological estradiol clamp and variable-waveform deconvolution model. [2007.09]
Dopamine versus dobutamine in very low birthweight infants: endocrine effects. [2007.09]
Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. [2007.09]
Evidence for distinct effects of GH and IGF-I in the metabolic syndrome. [2007.09]
Modulation of apolipoprotein A1 and B, adiponectin, ghrelin, and growth hormone concentrations by plant sterols and exercise in previously sedentary humans. [2007.09]
Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia. [2007.08]
Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age. [2007.08]
Superovulatory ovarian response in Mangalica gilts is not influenced by feeding level. [2007.08]
Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy. [2007.07.01]
Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial. [2007.07]
Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. [2007.07]
Efficacy and safety of a new ready-to-use recombinant human growth hormone solution. [2007.07]
Significant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes. [2007.07]
A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis. [2007.06]
Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. [2007.06]
Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement. [2007.06]
Growth hormone response to different consecutive stress stimuli in healthy men: is there any difference? [2007.06]
The effect of exercise type on immunofunctional and traditional growth hormone. [2007.06]
Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial. [2007.05.04]
Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects. [2007.05]
Effects of free fatty acids, growth hormone and growth hormone receptor blockade on serum ghrelin levels in humans. [2007.05]
Plasma agouti-related protein (AGRP), growth hormone, insulin responses to a single circuit-resistance exercise in male college students. [2007.05]
Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery. [2007.04.21]
Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study. [2007.04]
Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty. [2007.04]
Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy. [2007.04]
Recombinant Human Growth Hormone to Treat HIV-Associated Adipose Redistribution Syndrome: 12-Week Induction and 24-Week Maintenance Therapy. [2007.03.29]
Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial. [2007.03]
Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin. [2007.03]
Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients. [2007.03]
Recombinant human growth hormone in abstinent androgenic-anabolic steroid use: psychological, endocrine and trophic factor effects. [2007.02]
The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects. [2007.02]
Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans. [2007.01.15]
Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study. [2007.01]
The ghrelin response to exercise before and after growth hormone administration. [2007.01]
Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial. [2007.01]
A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency. [2007]
Decreased ghrelin-induced GH release in thyrotoxicosis: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH. [2007]
|
